Frank Boehm Looks At the Future of Nanomedicine

Cover art by Dr. Angelika Domschke, (Angelika Domschke Consulting, LLC)

 Nanotechnolgy  

Frank J. Boehm's recently released book, Nanomedical Device and Systems Design looks at the challenges, possibilities and future vision of nanomedical devices and systems design. The book is an attempt to explore a significant range of conceptual nanomedical components, devices and systems.

In Frank J. Boehm's recently released book, Nanomedical Device and Systems Design: Challenges, Possibilities, Visions examines the speculative and pioneering technology in depth.

The detail to which Boehm explores nanotechnology's potential to impact medicine led Aubrey de Grey to write that it will give, "even the cautious reader a substantial level of confidence that, once the most basic nuts and bolts of molecular manufacturing are available (and progress towards them is already encouraging), their application to some of our greatest needs may rapidly follow."

Related articles Jobs Outlook For Nanotechnology Looks Bright  Ralph Merkle On The Future of Nanotechnology  Eric Drexler Describes How Nanotechnology Will Create A New Kind of Revolution

The book considers the potential of future innovations that will involve nanomedical devices and systems. It endeavors to explore remarkable possibilities spanning medical diagnostics, therapeutics, and other advancements that may be enabled within this discipline.

In particular, this book investigates just how nanomedical diagnostic and therapeutic devices and systems might ultimately be designed and engineered to accurately diagnose and eradicate pathogens, toxins, and myriad disease states.

"One of my primary motivations for writing this book is to inspire, promote and hopefully expedite the development and implementation of beneficial advanced nanomedical diagnostic and therapeutic devices and systems."

"One of my primary motivations for writing this book is to inspire, promote and hopefully expedite the development and implementation of beneficial advanced nanomedical diagnostic and therapeutic devices and systems, which have strong potential to enable positive paradigm shifts in the field of medicine," states Boehm.   He also presents conceptual and laboratory derived examples of how sophisticated, highly efficient, minimally invasive and cost-effective nanotechnology advances in medicine may help people in both the developing and developed worlds.

Nanomedical Device and System Design also showcases a diverse group of expert contributing authors, who describe actual laboratory-based research aimed at the advancement of nanomedical capabilities. It also articulates more highly conceptual nanomedical possibilities and visions relating to the implementation of nanomedical technologies in remote regions and the developing world, as well as nanomedicine in space applications, human augmentation, and the potentially radical extension of the human life span.

For example, human lifespan could be extended by the removal of a substance called lipofuscin from certain types of non-dividing cells, including the brain, heart, liver, kidneys and eyes, Boehm told iO9's George Dvorsky. "Lipofuscin is a metabolic end product that accumulates primarily within lysosomes (the garbage disposal organelles within cells). It's thought that when lipofuscin accumulates to certain levels, it begins to negatively impact cell function, which eventually manifests in many age related conditions."

Boehm has been involved with nanotechnology and especially nanomedicine since 1996, which has inspired the development of numerous concepts and designs for advanced nanomedical diagnostic and therapeutic components, devices, and systems to potentially address myriad disease states. His aim is to develop and transform these concepts into real-world applications for global benefit.

Over the last decade, Frank has managed to engage the interest of Canadian, U.S. and International researchers in his nanomedical concepts, and in 2009 he formed the start-up company, NanoApps Medical, Inc. The aim of this company is to investigate and develop advanced, innovative, and cost-effective nanomedical diagnostic and therapeutic devices and systems.

By 33rd Square

Embed